IP Library Granted Patent US 7,417,022
Granted Patent B2
US 7,417,022 · App. 11/104,173 · Granted Aug 26, 2008

Compounds and compositions for delivering active agents

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,417,022
App. No.
11/104,173
Granted
Aug 26, 2008
Kind
B2
Abstract

Modified amino acid compounds useful in the delivery of active agents are provided. Methods of administration and preparation are provided as well.

Claims (78)

1. A pharmacological composition comprising:

(A) parathyroid hormone; and

(B) at least one carrier compound having the formula

2-HO—Ar—CONR 8 —R 7 —COOH

wherein Ar is a substituted or unsubstituted phenyl or naphthyl;

R 7 is selected from the group consisting of C 4 to C 20 alkyl, C 4 to C 20 alkenyl, phenyl, naphthyl, (C 1 to C 10 alkyl) phenyl, (C 1 to C 10 alkenyl)phenyl, (C 1 to C 10 alkyl) naphthyl, (C 1 to C 10 alkenyl)naphthyl, phenyl (C 1 to C 10 alkyl), phenyl (C 1 to C 10 alkenyl), naphthyl (C 1 to C 10 alkyl), and naphthyl (C 1 to C 10 alkenyl);

R 8 is selected from the group consisting of hydrogen, C 1 to C 4 alkyl, C 1 to C 4 alkenyl, hydroxy, and C 1 to C 4 alkoxy;

R 7 is optionally substituted with C 1 to C 4 alkyl, C 1 to C 4 alkenyl, C 1 to C 4 alkoxy, —OH, —SH and —CO 2 R 9 any combination thereof;

R 9 is hydrogen, C 1 to C 4 alkyl or C 1 to C 4 alkenyl;

R 7 is optionally interrupted by oxygen, nitrogen, sulfur or any combination thereof;

with the proviso that the compounds are not substituted with an amino group in the position alpha to the acid group;

or salts thereof.

2. The composition according to claim 1 , wherein R 7 is C 4 to C 20 alkyl.

3. The composition according to claim 1 , wherein R 7 is C 5 to C 20 alkyl.

4. The composition according to claim 1 wherein the carrier has the formula

or a salt thereof.

5. The composition according to claim 1 wherein said carrier is a compound selected from the group consisting of

or salts thereof.

6. The composition according to claim 1 wherein the carrier is a compound selected from the group consisting of

A

Compound

n

m

X

LII

1

0

2-OH

LIII

3

0

2,6-dihydroxy

LIV

2

0

2-OH

LVI

2

0

2,6-dihydroxy

or salts thereof.

7. The composition according to claim 1 wherein the carrier is a compound selected from the group consisting of

G

Compound

n

m

X

CXI

6

0

2-OH

CXIX

9

0

2-OH

or salts thereof.

8. The composition according to claim 1 , wherein said carrier has the formula

or a salt thereof.

9. The composition according to claim 1 wherein the carrier has the formula

or a salt thereof.

10. A dosage unit form comprising

(A) a pharmacological composition according to claim 1 ; and

(B) (a) an excipient,

(b) a diluent,

(c) a disintegrant,

(d) a lubricant,

(e) a plasticizer,

(f) a colorant,

(g) a dosing vehicle, or

(h) any combination thereof.

11. A dosage unit form according to claim 10 , comprising a tablet, a capsule, or a liquid.

12. A dosage unit form according to claim 11 , wherein said dosing vehicle is selected from the group consisting of water, 1,2-propane diol, ethanol or any combination thereof.

13. A method for administering parathyroid hormone to a mammal in need of said agent, said method comprising administering orally to said mammal a composition as defined in claim 1 .

14. A method for preparing a pharmacological composition, said method comprising mixing:

(A) parathyroid hormone;

(B) at least one carrier compound according to claim 1 ; and

(C) optionally a dosing vehicle.

15. A method for administering parathyroid hormone to an animal in need thereof, said method comprising administering orally to said mammal a composition as defined in claim 1 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2021
From: EMISPHERE TECHNOLOGIES, INC.
To: NOVO NORDISK NORTH AMERICA OPERATIONS A/S
Reel/Frame 056750/0169 →
SECURITY AGREEMENT Recorded Oct 3, 2005
From: EMISPHERE TECHNOLOGIES, INC.
To: MHR INSTITUTIONAL PARTNERS IIA LP
Reel/Frame 016617/0145 →